Frail; Donald E.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Frail; Donald E..The latest application filed is for "botulinum toxin cell binding domain polypeptides and methods of use for treatments of fibrosis associated disorders".

Company Profile

2.2.11

Frail; Donald E. - Laguna Hills CA
Frail; Donald E. - Natick MA
Frail; Donald E. - Wildwood MO
Frail; Donald E. - Libertyville IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Botulinum toxin cell binding domain polypeptides and methods of use for skin rejuvenation Grant 11,149,262 - Jacky , et al. October 19, 2	2021-10-19
Botulinum Toxin Cell Binding Domain Polypeptides And Methods Of Use For Treatments Of Fibrosis Associated Disorders App 20210277377 - Jacky; Birgitte PS ; et al.	2021-09-09
Botulinum Toxin Cell Binding Domain Polypeptides And Methods Of Use For Treatments Of Fibrosis Associated Disorders App 20190185837 - Jacky; Birgitte PS ; et al.	2019-06-20
Botulinum Toxin Cell Binding Domain Polypeptides And Methods Of Use For Skin Rejuvenation App 20190185523 - Jacky; Birgitte PS ; et al.	2019-06-20
Characterization Of A Membrane Estrogen Receptor App 20090029382 - Deecher; Darlene C. ; et al.	2009-01-29
Methods for identifying and using amyloid-inhibitory compounds App 20080085244 - Petanceska; Suzana ; et al.	2008-04-10
Characterization of a membrane estrogen receptor App 20060287226 - Deecher; Darlene C. ; et al.	2006-12-21
Characterization of a membrane estrogen receptor App 20060116317 - Deecher; Darlene C. ; et al.	2006-06-01
Use of 4-phenyl-substituted tetrahydroisoquinolines in the treatment of pain, migraine headaches and urinary incontinence App 20040248933 - Frail, Donald E. ; et al.	2004-12-09
Use of 4-phenyl substituted tetrahydroisoquinolines in the treatment of pain, migraine and urinary incontinence App 20040248925 - Frail, Donald E. ; et al.	2004-12-09
Use of aryl- and heteroaryl-substituted tetrahydroisoquinolines in the treatment of chronic and neuropathic pain, migraine headaches, and urge, stress and mixed urinary incontinence App 20040248932 - Frail, Donald E. ; et al.	2004-12-09
Characterization of a membrane estrogen receptor App 20040180819 - Deecher, Darlene C. ; et al.	2004-09-16
Hepatitis C virus fusion proteins Grant 5,854,001 - Casey , et al. December 29, 1	1998-12-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.